Showing results (101-110 of 233) with videos related to
Sort By:
Pageof 24
Blood|May 27, 2008
First thalidomide clinical trial in multiple myeloma: a decadeFrits van Rhee, Madhav Dhodapkar, John D Shaughnessy, et al.Blood|October 7, 2006
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosisFenghuang Zhan, Bart Barlogie, Varant Arzoumanian, et al.Blood|October 20, 2007
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myelomaJumei Shi, Guido J Tricot, Tarun K Garg, et al.Blood Neoplasia|July 24, 2024
Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccinationSaishravan Shyamsundar, Sheila K Pierson, Caoilfhionn M Connolly, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's diseaseFrits van Rhee, Luis Fayad, Peter Voorhees, et al.British Journal of Haematology|December 13, 2006
Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering diseaseMauricio Pineda-Roman, Vanessa Bolejack, Varant Arzoumanian, et al.Blood|May 16, 2009
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myelomaTwyla B Bartel, Jeff Haessler, Tracy L Y Brown, et al.Plos One|February 2, 2013
Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levelsKatie Stone, Emily Woods, Susann M Szmania, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 24, 2025
The Involvement of PI3K-Akt Signaling in the Clinical and Pathological Findings of Idiopathic Multicentric Castleman Disease-Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, and Organomegaly and Not Otherwise Specified SubtypesTomoka Haratake, Midori Filiz Nishimura, Asami Nishikori, et al.British Journal of Haematology|August 26, 2004
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationMaurizio Zangari, Bart Barlogie, Elias Anaissie, et al.Pageof 24